510(k) device
Innovo
Atlantic Therapeutics, Ltd. · Cutaneous Electrode Stimulator For Urinary Incontinence (QAJ, Class II) · First FDA decision Jan 16, 2020, newest Jan 16, 2020Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Innovo"
MAUDE reports
13
Brand "Innovo", since 2015
PubMed studies
15
Mentioning "Innovo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Innovo
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- INNOVO510(k)
K192357 · Decided Jan 16, 2020 · 140 days after receipt
Device type: Cutaneous Electrode Stimulator For Urinary Incontinence (QAJ) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Home Biofeedback For Urinary IncontinenceNational analysisReview closedCAG-00118NUpdated Sep 14, 2026
- Biofeedback for Urinary IncontinenceNational analysisReview closedCAG-00020NUpdated Sep 14, 2026
- Sacral Nerve Stimulation For Urinary IncontinenceNational determinationOn the books230.18Updated Dec 8, 2025
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Biofeedback Therapy for the Treatment of Urinary IncontinenceNational determinationOn the books30.1.1Updated Sep 24, 2015
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Innovo", any status and sponsor, newest update first.
Selcuk UniversityAcademic, hospital or other
NCT06935240 · 37 participants · Start Mar 10, 2025 · Primary completion May 30, 2026
Device: Treatment · For: Overactive Bladder
Sites: Konya, Turkey (Türkiye)
Indiana UniversityAcademic, hospital or other
NCT05784103 · 20 participants · Start Mar 9, 2022 · Primary completion Jul 7, 2022
Device: Clarifi Modulum; Perimed PeriFlux 5000 and 2 more · For: Oxygen Saturation
Sites: Indianapolis, Indiana; Pittsburgh, Pennsylvania
- The Effects of Neuromuscular Electrical Stimulation in Individuals With Urinary Incontinence After ProstatectomyStatus unknown
Ankara Yildirim Beyazıt UniversityAcademic, hospital or other
NCT05236088 · 50 participants (planned) · Start Mar 2022 · Primary completion Jul 2022
Device: Neuromuscular electrical stimulation application; Sham neuromuscular electrical stimulation application · For: Urinary Incontinence
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Innovo", and for the whole product code for context.
This brand
13 reports: 4 malfunction, 9 injury, 0 death
Whole product code QAJ
12 reports: 3 malfunction, 9 injury, 0 death
Newest reports for this brand
- INNOVO, TYPE NUMBER 208Injury
3015223097-2024-00001 · Received Mar 14, 2024 · Event dated May 1, 2023
Device type: Cutaneous Electrode Stimulator For Urinary Incontinence (QAJ)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
Patient problem as coded: Transient Ischemic Attack; Insufficient Information
- INNOVO, TYPE NUMBER 207Malfunction
3015223097-2023-00010 · Received Aug 3, 2023 · Event dated Jan 5, 2021
Device type: Cutaneous Electrode Stimulator For Urinary Incontinence (QAJ)
Device problem as coded: Stretched
Patient problem as coded: Dizziness; Insufficient Information
- INNOVO, TYPE NUMBER 208Malfunction
3015223097-2023-00011 · Received Aug 3, 2023 · Event dated May 12, 2021
Device type: Cutaneous Electrode Stimulator For Urinary Incontinence (QAJ)
Device problem as coded: Stretched
Patient problem as coded: Numbness; Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Innovo"[tiab]. The summary above synthesizes these.
- Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ, Finer NN · Cochrane Database Syst Rev · 2006Meta-Analysis, Systematic Review
- Efficacy and safety performance of the Innovo insulin doser.
Valk NK, Cerny G, Sieber J, et al. · Diabetes Technol Ther · 2004Clinical Trial, Comparative Study
- Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ, Finer NN · Cochrane Database Syst Rev · 2007Meta-Analysis, Systematic Review
- Nitric oxide for respiratory failure in infants born at or near term.
Barrington KJ, Finer N, Pennaforte T, et al. · Cochrane Database Syst Rev · 2017Meta-Analysis, Research Support, N.I.H., Extramural
- Recovery of a dilated left ventricle after cessation of cocaine and HVADࡊ explantation using a titanium plug.
Elbayomi M, Weyand M, Seitz T, et al. · J Card Surg · 2022Case Reports
- Innovo GenMax MTB-RIF/INH: a moderate-complexity automated NAAT for rapid simultaneous detection of Mycobacterium tuberculosis complex and rifampin/isoniazid resistance.
Ou X, Zhao B, Zheng H, et al. · Front Cell Infect Microbiol · 2025Evaluation Study
- Respiratory function during infancy in survivors of the INNOVO trial.
Hoo AF, Beardsmore CS, Castle RA, et al. · Pediatr Pulmonol · 2009Comparative Study, Research Support, Non-U.S. Gov't
- External electrical stimulation compared with intravaginal electrical stimulation for the treatment of stress urinary incontinence in women: A randomized controlled noninferiority trial.
Dmochowski R, Lynch CM, Efros M, et al. · Neurourol Urodyn · 2019Comparative Study, Equivalence Trial
- A nurse educator's perspective on the Innovo insulin delivery system.
Bonsignore P, Ghiloni S, Lekarcyk J · Diabetes Technol Ther · 2004Comment, Comparative Study
- The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years.
Huddy CL, Bennett CC, Hardy P, et al. · Arch Dis Child Fetal Neonatal Ed · 2008Multicenter Study, Randomized Controlled Trial
- InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference.
Haupt A, Berg B, Paschen P, et al. · Exp Clin Endocrinol Diabetes · 2005Comparative Study, Multicenter Study
- Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).
Field D, Elbourne D, Truesdale A, et al. · Pediatrics · 2005Clinical Trial, Multicenter Study
Other devices of this type
Also filed under product code QAJ.
- Elitone for MenElidah, Inc. · 510(k) 2026
- ELITONE Urge Urinary Incontinence DeviceElidah, Inc. · 510(k) 2023
- InnovoBio-Medical Research, Ltd. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.